Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Biofrontera (BFRI) Equity Ratio: 2020-2025

Historic Equity Ratio for Biofrontera (BFRI) over the last 4 years, with Sep 2025 value amounting to -0.17.

  • Biofrontera's Equity Ratio fell 156.06% to -0.17 in Q3 2025 from the same period last year, while for Sep 2025 it was -0.17, marking a year-over-year decrease of 156.06%. This contributed to the annual value of 0.20 for FY2024, which is 16.89% up from last year.
  • Latest data reveals that Biofrontera reported Equity Ratio of -0.17 as of Q3 2025, which was up 27.75% from -0.23 recorded in Q2 2025.
  • In the past 5 years, Biofrontera's Equity Ratio registered a high of 0.51 during Q2 2024, and its lowest value of -1.13 during Q3 2021.
  • Moreover, its 3-year median value for Equity Ratio was 0.10 (2023), whereas its average is 0.10.
  • As far as peak fluctuations go, Biofrontera's Equity Ratio spiked by 881.26% in 2024, and later crashed by 156.06% in 2025.
  • Biofrontera's Equity Ratio (Quarterly) stood at 0.21 in 2021, then soared by 120.27% to 0.47 in 2022, then crashed by 63.43% to 0.17 in 2023, then grew by 16.89% to 0.20 in 2024, then tumbled by 156.06% to -0.17 in 2025.
  • Its Equity Ratio stands at -0.17 for Q3 2025, versus -0.23 for Q2 2025 and 0.03 for Q1 2025.